NASH

NASH

Nonalcoholic steatohepatitis (NASH) is a serious progressive liver disease that causes fat accumulation and inflammation that is not related to excess alcohol consumption. As a growing public health concern, NASH can progress to fibrosis, cirrhosis, liver cancer, and death and is a leading cause of liver failure requiring transplantation. Because NASH is directly related to the diabetes and obesity epidemics, continuing medical education (CME on NASH is a critical part of healthcare professional education. It is vital that practitioners stay updated on the emerging NASH treatment landscape so that they are well poised to treat patients when effective therapies become available. NASH CME and CE programs can help medical personnel and their patients understand the causes and consequences of NASH and the importance of early diagnosis and treatment that can reduce the chances of devastating NASH-related complications.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?